97 related articles for article (PubMed ID: 11928810)
1. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion.
Ryniers F; Stove C; Goethals M; Brackenier L; Noë V; Bracke M; Vandekerckhove J; Mareel M; Bruyneel E
Biol Chem; 2002 Jan; 383(1):159-65. PubMed ID: 11928810
[TBL] [Abstract][Full Text] [Related]
2. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032
[TBL] [Abstract][Full Text] [Related]
3. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
[TBL] [Abstract][Full Text] [Related]
4. Truncated E-cadherin potentiates cell death in prostate epithelial cells.
Rios-Doria J; Day ML
Prostate; 2005 May; 63(3):259-68. PubMed ID: 15538719
[TBL] [Abstract][Full Text] [Related]
5. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding.
De Wever O; Westbroek W; Verloes A; Bloemen N; Bracke M; Gespach C; Bruyneel E; Mareel M
J Cell Sci; 2004 Sep; 117(Pt 20):4691-703. PubMed ID: 15331629
[TBL] [Abstract][Full Text] [Related]
6. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator/plasmin system suppresses cell-cell adhesion of oral squamous cell carcinoma cells via proteolysis of E-cadherin.
Hayashido Y; Hamana T; Yoshioka Y; Kitano H; Koizumi K; Okamoto T
Int J Oncol; 2005 Sep; 27(3):693-8. PubMed ID: 16077918
[TBL] [Abstract][Full Text] [Related]
8. Alpha-catenin is required for IGF-I-induced cellular migration but not invasion in human colonic cancer cells.
André F; Janssens B; Bruyneel E; van Roy F; Gespach C; Mareel M; Bracke M
Oncogene; 2004 Feb; 23(6):1177-86. PubMed ID: 14961074
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin regulates the association between beta-catenin and actinin-4.
Hayashida Y; Honda K; Idogawa M; Ino Y; Ono M; Tsuchida A; Aoki T; Hirohashi S; Yamada T
Cancer Res; 2005 Oct; 65(19):8836-45. PubMed ID: 16204054
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
11. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.
Noë V; Fingleton B; Jacobs K; Crawford HC; Vermeulen S; Steelant W; Bruyneel E; Matrisian LM; Mareel M
J Cell Sci; 2001 Jan; 114(Pt 1):111-118. PubMed ID: 11112695
[TBL] [Abstract][Full Text] [Related]
12. Soluble fragment of P-cadherin adhesion protein found in human milk.
Soler AP; Russo J; Russo IH; Knudsen KA
J Cell Biochem; 2002; 85(1):180-4. PubMed ID: 11891861
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.
Johnson SK; Ramani VC; Hennings L; Haun RS
Cancer; 2007 May; 109(9):1811-20. PubMed ID: 17354228
[TBL] [Abstract][Full Text] [Related]
14. Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage.
Fuchs M; Hermannstädter C; Hutzler P; Häcker G; Haller F; Höfler H; Luber B
Exp Cell Res; 2008 Jan; 314(1):153-63. PubMed ID: 17959171
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.
Jaggi M; Rao PS; Smith DJ; Wheelock MJ; Johnson KR; Hemstreet GP; Balaji KC
Cancer Res; 2005 Jan; 65(2):483-92. PubMed ID: 15695390
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans.
Frank CF; Hostetter MK
Transl Res; 2007 Apr; 149(4):211-22. PubMed ID: 17383595
[TBL] [Abstract][Full Text] [Related]
17. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel dual E- and N-cadherin antagonist.
Devemy E; Blaschuk OW
Peptides; 2009 Aug; 30(8):1539-47. PubMed ID: 19465078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
